Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Randall Schatzman is active.

Publication


Featured researches published by Randall Schatzman.


American Journal of Medical Genetics | 2002

A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.

Karen Staehling-Hampton; Sean Proll; Bryan W. Paeper; Lei Zhao; Patrick Charmley; Analisa Brown; Jessica Gardner; David J. Galas; Randall Schatzman; Peter Beighton; Socrates E. Papapoulos; Herman Hamersma; Mary E. Brunkow


American Journal of Human Genetics | 2004

Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites

André G. Uitterlinden; Pascal P. Arp; Bryan W. Paeper; Patrick Charmley; Sean Proll; Fernando Rivadeneira; Yue Fang; Joyce B. J. van Meurs; Theresa B. Britschgi; John Latham; Randall Schatzman; Huibert A. P. Pols; Mary E. Brunkow


Archive | 2004

METHODS OF SYNTHESIZING HETEROMULTIMERIC POLYPEPTIDES IN YEAST USING A HAPLOID MATING STRATEGY

James M. Cregg; John Latham; Mark Litton; Randall Schatzman; Ilya Tolstorukov


Archive | 2011

Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Jeffrey T. L. Smith; Randall Schatzman; Mark Litton; John A. Latham


Archive | 2009

Methods of treating anemia using anti-IL-6 antibodies

Jeffrey T. L. Smith; John A. Latham; Mark Litton; Randall Schatzman


Archive | 2009

Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments

Leon F. Garcia-Martinez; Anne Elisabeth Carvalho Jensen; Katie Olson; Ben Dutzar; John A. Latham; Brian Kovacevich; Jeffrey T. L. Smith; Mark Litton; Randall Schatzman


Archive | 2017

ANTIBODY TO IL-6 AND USE THEREOF

Leon F. Garcia-Martinez; Anne Elisabeth Carvalho Jensen; Katie Olson; Ben Dutzar; Latham John; Brian Kovacevich; Jeffrey T. L. Smith; Litton Mark; Randall Schatzman


Archive | 2017

Subcutaneously administrable composition containing anti-IL-6 antibody

Leon F. Garcia-Martinez; Anne Elisabeth Carvalho Jensen; Katie Anderson; Benjamin H. Dutzar; John A. Latham; Brian Kovacevich; Jeffrey T. L. Smith; Mark Litton; Randall Schatzman


Archive | 2017

Anti-IL-6 antibody for use in the treatment of cachexia

Jeffrey T. L. Smith; John A. Latham; Mark Litton; Randall Schatzman


Archive | 2015

***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity

Jeffrey T. L. Smith; John A. Latham; Mark Litton; Randall Schatzman

Collaboration


Dive into the Randall Schatzman's collaboration.

Top Co-Authors

Avatar

Mark Litton

Keck Graduate Institute of Applied Life Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John A. Latham

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John Latham

Keck Graduate Institute of Applied Life Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ilya Tolstorukov

Keck Graduate Institute of Applied Life Sciences

View shared research outputs
Top Co-Authors

Avatar

James M. Cregg

Keck Graduate Institute of Applied Life Sciences

View shared research outputs
Top Co-Authors

Avatar

Patrick Charmley

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge